Publication:
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease

dc.contributor.authorNeuböck, Matthias J. (57221701704)
dc.contributor.authorGünther, Gunar (36607942800)
dc.contributor.authorBarac, Aleksandra (55550748700)
dc.contributor.authorDavidsen, Jesper R. (12805232600)
dc.contributor.authorLaursen, Christian B. (25643079200)
dc.contributor.authorAgarwal, Ritesh (35518434600)
dc.contributor.authorSehgal, Inderpaul S. (55762186000)
dc.contributor.authorLange, Christoph (55516057600)
dc.contributor.authorSalzer, Helmut J.F. (36118318800)
dc.date.accessioned2025-06-12T11:49:06Z
dc.date.available2025-06-12T11:49:06Z
dc.date.issued2024
dc.description.abstractPost-tuberculosis lung disease (PTLD) has only recently been put in the spotlight as a medical entity. Recent data suggest that up to 50% of tuberculosis (TB) patients are left with PTLD-related impairment after completion of TB treatment. The presence of residual cavities in the lung is the largest risk factor for the development of chronic pulmonary aspergillosis (CPA) globally. Diagnosis of CPA is based on four criteria including a typical radiological pattern, evidence of Aspergillus species, exclusion of alternative diagnosis, and a chronic course of disease. In this manuscript, we provide a narrative review on CPA as a serious complication for patients with PTLD. © 2024. Thieme. All rights reserved.
dc.identifier.urihttps://doi.org/10.1055/s-0043-1776913
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85182650501&doi=10.1055%2fs-0043-1776913&partnerID=40&md5=b3973e4d044d68c8b90d83948a88a90f
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1352
dc.subjectAspergillus
dc.subjectchronic pulmonary aspergillosis
dc.subjectfungal infection
dc.subjectpost-tuberculosis disease
dc.subjectpost-tuberculosis lung disease
dc.titleChronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease
dspace.entity.typePublication

Files